Page last updated: 2024-09-03

1-(2-nitro-1-imidazoly)-3-(2,3-dimethylaziridino)-2-propanol and EHS Tumor

1-(2-nitro-1-imidazoly)-3-(2,3-dimethylaziridino)-2-propanol has been researched along with EHS Tumor in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Siemann, DW; Sutherland, RM1
Siemann, DW2
Adams, GE; Cole, S; Fielden, EM; Jenkins, TC; Stratford, IJ1
Deacon, J; Holliday, S; Stratford, IJ; Walling, JM1
Hofer, KG; Hofer, MG; Lakkis, M1

Other Studies

6 other study(ies) available for 1-(2-nitro-1-imidazoly)-3-(2,3-dimethylaziridino)-2-propanol and EHS Tumor

ArticleYear
Potentiation of alkylating chemotherapy by dual function nitrofurans in multi-cell spheroids and solid tumors.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1992, Volume: 24, Issue:4

    Topics: Animals; Antineoplastic Agents; Aziridines; Bone Marrow; Carcinoma; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Lomustine; Mice; Mice, Inbred C3H; Mice, Inbred Strains; Misonidazole; Nitrofurans; Radiation-Sensitizing Agents; Sarcoma, Experimental; Stem Cells; Tumor Cells, Cultured

1992
Enhancement of chemotherapy and nitroimidazole-induced chemopotentiation by the vasoactive agent hydralazine.
    British journal of cancer, 1990, Volume: 62, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Hypoxia; Cyclophosphamide; Drug Synergism; Female; Hydralazine; Lomustine; Melphalan; Mice; Mice, Inbred C3H; Misonidazole; Sarcoma, Experimental; Stem Cells

1990
Dual-function 2-nitroimidazoles as hypoxic cell radiosensitizers and bioreductive cytotoxins: in vivo evaluation in KHT murine sarcomas.
    Radiation research, 1990, Volume: 124, Issue:1 Suppl

    Topics: Animals; Antineoplastic Agents; Female; Mice; Mice, Inbred C3H; Misonidazole; Prodrugs; Radiation-Sensitizing Agents; Sarcoma, Experimental

1990
High uptake of RSU 1069 and its analogues melanotic melanomas.
    Cancer chemotherapy and pharmacology, 1989, Volume: 24, Issue:1

    Topics: Animals; Cell Line; Cell Membrane Permeability; Deoxyribonucleases; Drug Evaluation, Preclinical; Half-Life; Humans; Lung Neoplasms; Male; Melanoma; Mice; Mice, Inbred Strains; Microbial Collagenase; Misonidazole; Sarcoma, Experimental; Tissue Distribution; Trypsin; Tumor Cells, Cultured

1989
The chemosensitizing and cytotoxic effects of RSU 1164 and RSU 1165 in a murine tumor model.
    International journal of radiation oncology, biology, physics, 1989, Volume: 16, Issue:4

    Topics: Animals; Antineoplastic Agents; Cell Survival; Drug Synergism; Lomustine; Mice; Misonidazole; Oxygen; Radiation-Sensitizing Agents; Sarcoma, Experimental; Tumor Cells, Cultured; Tumor Stem Cell Assay

1989
Cytocidal effects of misonidazole, Ro 03-8799, and RSU-1164 on euoxic and hypoxic BP-8 murine sarcoma cells at normal and elevated temperatures.
    Cancer, 1989, Apr-15, Volume: 63, Issue:8

    Topics: Animals; Combined Modality Therapy; Female; Hyperthermia, Induced; Iodine Radioisotopes; Mice; Misonidazole; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Sarcoma, Experimental; Tumor Cells, Cultured

1989